Literature DB >> 29599320

MicroRNA-96 Promotes Tumor Invasion in Colorectal Cancer via RECK.

Yasuhito Iseki1, Masatsune Shibutani2, Kiyoshi Maeda1, Hisashi Nagahara1, Tatsunari Fukuoka1, Shinji Matsutani1, Kosei Hirakawa1, Masaichi Ohira1.   

Abstract

BACKGROUND: miR-96 is reported to inhibit reversion cysteine-rich Kazal motif (RECK), which is associated with tumor invasion, in solid cancer types (e.g. breast cancer, non-small cell lung cancer, esophageal cancer). The purpose of this study is to clarify whether miR-96 is similarly associated with tumor invasion in colorectal cancer.
MATERIALS AND METHODS: We performed western blotting to investigate the expression of RECK when miR-96 mimics or inhibitors were transferred into HCT-116 colorectal cancer cells. The RECK mRNA level was assessed by a reverse transcription polymerase chain reaction. An invasion assay was used to evaluate tumor invasion.
RESULTS: The expression of RECK was inhibited by the transfection of miR-96 mimics. RECK mRNA level was reduced by miR-96 mimics and increased by miR-96 inhibitor. In the invasion assay, miR-96 mimics were shown to promote tumor invasion.
CONCLUSION: miR-96 may be associated with tumor invasion through inhibition of RECK expression in colorectal cancer. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  MiR-96; MicroRNA; RECK; cell invasion; colorectal cancer

Mesh:

Substances:

Year:  2018        PMID: 29599320     DOI: 10.21873/anticanres.12442

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Low expression of RECK in oral squamous cell carcinoma patients induces a shorter survival rate through an imbalance of RECK/MMPs.

Authors:  Jian Yuan; Wen Li; Jinxiao Zhu; Shuli Deng; Xuejin Tao
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

2.  Integrated bioinformatics analysis reveals role of the LINC01093/miR-96-5p/ZFAND5/NF-κB signaling axis in hepatocellular carcinoma.

Authors:  Yahui Zheng; Kangkang Yu; Chong Huang; Lu Liu; Hao Zhao; Meisi Huo; Jubo Zhang
Journal:  Exp Ther Med       Date:  2019-09-25       Impact factor: 2.447

3.  MicroRNA-96-3p promotes metastasis of papillary thyroid cancer through targeting SDHB.

Authors:  Xupeng Zhao; Yingjie Li; Yong Zhou
Journal:  Cancer Cell Int       Date:  2019-11-12       Impact factor: 5.722

Review 4.  MicroRNAs and 'Sponging' Competitive Endogenous RNAs Dysregulated in Colorectal Cancer: Potential as Noninvasive Biomarkers and Therapeutic Targets.

Authors:  Brian G Jorgensen; Seungil Ro
Journal:  Int J Mol Sci       Date:  2022-02-16       Impact factor: 5.923

5.  Circular RNA circ_0089153 acts as a competing endogenous RNA to regulate colorectal cancer development by the miR-198/SUMO-specific peptidase 1 (SENP1) axis.

Authors:  Guan Fang; Tingting Chen; Ruibo Mao; Xiaming Huang; Ling Ji
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 6.  Epigenetic Regulation by lncRNAs: An Overview Focused on UCA1 in Colorectal Cancer.

Authors:  Bernadette Neve; Nicolas Jonckheere; Audrey Vincent; Isabelle Van Seuningen
Journal:  Cancers (Basel)       Date:  2018-11-14       Impact factor: 6.639

7.  miR-106b-5p inhibits the invasion and metastasis of colorectal cancer by targeting CTSA.

Authors:  Shujuan Ni; Weiwei Weng; Midie Xu; Qifeng Wang; Cong Tan; Hui Sun; Lei Wang; Dan Huang; Xiang Du; Weiqi Sheng
Journal:  Onco Targets Ther       Date:  2018-07-04       Impact factor: 4.147

8.  Exosomal miR-182 regulates the effect of RECK on gallbladder cancer.

Authors:  Hong Zheng; Jin-Jing Wang; Li-Jin Zhao; Xiao-Rong Yang; Yong-Lin Yu
Journal:  World J Gastroenterol       Date:  2020-03-07       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.